By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions
Pharma determines access, pricing, supply, and exits, the four pillars of GLP-1 market stability.(e.g., Roche, AbbVie, Novo Nordisk) They control the drug pipeline and reimbursement Pharmas licensing, M&A, and distribution decisions determine what products clinicians can prescribe and what insurers will cover
GLP-1, or glucagon-like peptide-1, is an incretin hormone produced primarily by enteroendocrine L cells in the small intestine and colon
Unlike many international vendors that require dealing with customs delays, import fees, and uncertain delivery times, the company focuses exclusively on customers within Costa Rica, creating a much smoother purchasing experience
Applied in copper-transport and gene-expression research assays